Unlike single or dual-receptor agonists, this pharmaceutical-grade peptide requires precise handling to maintain its complex molecular structure and therapeutic potency
Users often describe feeling normal again while still experiencing strong appetite suppression
Transdermal delivery systems may additionally cause local skin reactions , including redness, itching, or irritation at the application site
Oral options could unlock easier access and fewer logistical headaches
Onset: typically 2 to 4 months after starting treatment or a dose increase
Such statements include, but are not limited to, any statements relating to our financial outlook and guidance, including our mission to drive top-line growth and profitability and our ability to attain our medium- and long-term financial targets